Results 301 to 310 of about 1,566,936 (371)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Journal of Clinical Oncology, 2021
4080 Background: Second-line treatment options for patients with biliary tract cancers (BTC) are limited. Lenvatinib, an anti-angiogenic multikinase inhibitor, in combination with the programmed death-1 immune checkpoint inhibitor pembrolizumab, has ...
L. Villanueva +19 more
semanticscholar +1 more source
4080 Background: Second-line treatment options for patients with biliary tract cancers (BTC) are limited. Lenvatinib, an anti-angiogenic multikinase inhibitor, in combination with the programmed death-1 immune checkpoint inhibitor pembrolizumab, has ...
L. Villanueva +19 more
semanticscholar +1 more source
Journal of Neurosurgery, 2020
OBJECTIVE Trigeminal schwannomas are rare neoplasms with an incidence of less than 1% that require a comprehensive surgical strategy. These tumors can occur anywhere along the path of the trigeminal nerve, capable of extending intradurally into the ...
H. Park +6 more
semanticscholar +1 more source
OBJECTIVE Trigeminal schwannomas are rare neoplasms with an incidence of less than 1% that require a comprehensive surgical strategy. These tumors can occur anywhere along the path of the trigeminal nerve, capable of extending intradurally into the ...
H. Park +6 more
semanticscholar +1 more source

